Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Does faecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?

< BACK TO ARCHIVE


2021 Apr 08


Minerva Gastroenterol (Torino)


http://www.ncbi.nlm.nih.gov/pubmed/33829725?dopt=Abstract

Does faecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?

Authors

Does faecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome?
Guingand de Rivery M, Zeinab H, Cohen V, Baumstarck K, Luciano L, Vitton V
Minerva Gastroenterol (Torino). 2021 Apr 08.
PMID: 33829725.

Abstract

Irritable bowel syndrome (IBS) is a multifactorial condition without any specific investigation. Faecal calprotectin (FC) may be elevated in IBS without any explanation. In addition, some patients with IBS have symptoms related to lactose intolerance.
Read This Paper